The cannabinoid CB 1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

Author： Tzavara E.T. Perry K.W. Rodriguez D.E. Bymaster F.P. Nomikos G.G.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.426, Iss.3, 2001-08, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The cannabinoid CB 1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2

By Darmani N.A.

European Journal of Pharmacology, Vol. 430, Iss. 1, 2001-10 ,pp. : 49-58

Elsevier

Access to resources Recommend Favorite

Effects of the cannabinoid CB 1 receptor antagonist, SR141716A, after 9 -tetrahydrocannabinol withdrawal

By Beardsley P.M. Martin B.R.

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB₁ receptor antagonist

By Järbe Torbjörn Harris Michele Li Chen Liu Qian Makriyannis Alexandros

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the reinforcing effects of the cannabinoid CB 1 receptor antagonist, SR141716, in rhesus monkeys

By Beardsley P.M. Dance M.E. Balster R.L. Munzar P.

European Journal of Pharmacology, Vol. 435, Iss. 2, 2002-01 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite

Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB 1 receptor antagonist, SR 141716

By Vacca G. Serra S. Brunetti G. Carai M.A.M. Gessa G.L. Colombo G.

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 55-59

Elsevier

Access to resources Recommend Favorite